Published in Clin Exp Immunol on January 01, 1998
Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26
Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer (2003) 1.65
A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol (2005) 1.31
Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunol (2010) 1.10
Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls. Mediators Inflamm (2007) 0.92
Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol (1998) 0.92
Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer (2013) 0.89
The paradox of IL-10-mediated modulation in cervical cancer. Biomed Rep (2013) 0.85
Methylation patterns of the IFN-γ gene in cervical cancer tissues. Sci Rep (2014) 0.79
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells. Cancer Cell Int (2017) 0.75
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today (1996) 12.12
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Evidence for a differential avidity model of T cell selection in the thymus. Cell (1994) 5.24
Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol (1995) 3.20
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol (1996) 3.09
IL-12: initiation cytokine for cell-mediated immunity. Science (1993) 2.97
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst (1997) 2.45
The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA (1989) 2.34
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res (1994) 1.64
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet (1994) 1.52
HLA-DOB1*03 and cervical intraepithelial neoplasia grades I-III. Lancet (1993) 1.49
Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res (1995) 1.44
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol (1995) 1.42
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res (1996) 1.39
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol (1997) 1.34
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci U S A (1992) 1.31
Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer (1994) 1.27
Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens (1993) 1.22
Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer (1995) 1.17
Expression of interleukin 10 in human melanoma. Br J Cancer (1994) 1.15
Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol (1993) 1.14
Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol (1996) 1.12
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res (1996) 1.08
Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol (1995) 1.00
Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst (1997) 0.99
A double-blind study of the comparative incidence of malignancy and allergy. J Allergy (1967) 0.99
Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer (1994) 0.96
Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer (1996) 0.92
Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int Immunol (1996) 0.92
Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res (1994) 0.88
Immunology of the human papilloma virus in relation to cancer. Curr Opin Immunol (1994) 0.87
Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur J Cancer (1994) 0.85
Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes. Jpn J Cancer Res (1995) 0.84
Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell Immunol (1991) 0.84
Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer (1993) 0.83
Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia (1992) 0.82
Cellular immunity in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol (1978) 0.77
Efficient immunoselection of cytolytic effectors with a magnetic cell sorter. Res Immunol (1993) 0.77
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol (2008) 3.07
HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.80
Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol (1991) 1.75
Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg (1996) 1.45
Misdiagnosed malignancy in transplanted organs. Transpl Int (1993) 1.40
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
Patch testing in children: a study of 562 schoolchildren. Contact Dermatitis (1991) 1.39
An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res (1991) 1.38
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis (2013) 1.37
Prognosis of chronic persistent hepatitis. Lancet (1970) 1.35
Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr (1999) 1.35
Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL/Ka mice. Int J Cancer (1979) 1.35
Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president's emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS (2011) 1.30
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30
Identification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res (1995) 1.24
Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci (1996) 1.18
Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians. Ann Oncol (2006) 1.16
Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J Neuroendocrinol (2008) 1.15
Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization. Eur J Immunol (1984) 1.12
High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology (2005) 1.10
An unusual pituitary pathology. J Clin Endocrinol Metab (1998) 1.10
A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3' of the Ig H chain gene cluster. J Immunol (1992) 1.09
Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol (1995) 1.07
Lipases and esterases: a review of their sequences, structure and evolution. Biotechnol Annu Rev (1995) 1.07
Dyad symmetry within the mouse 3' IgH regulatory region includes two virtually identical enhancers (C alpha3'E and hs3). J Immunol (1997) 1.05
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. Br J Cancer (2003) 1.05
Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05
Jaundice associated with naproxen. Postgrad Med J (1980) 1.05
Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. J Endocrinol (2003) 1.02
Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology (2002) 1.02
Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol (2008) 1.01
Calcifying fibrous tumour of the gastric wall. Histopathology (2004) 1.00
Cytochemistry of mouse mast cell reaction to polylysine. Histochemistry (1980) 1.00
Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol Res (1998) 1.00
Functional anatomy of the thoracic outlet: evaluation with spiral CT. Radiology (1997) 0.98
Histopathology of portal hypertension: a practical guideline. Histopathology (2003) 0.98
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol (2002) 0.97
The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science (1986) 0.96
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clin Belg (2002) 0.95
Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol (1998) 0.94
Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer (1990) 0.93
Proviral genome of radiation leukemia virus: molecular cloning of biologically active proviral DNA and nucleotide sequence of its long terminal repeat. J Virol (1985) 0.93
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? Eur J Clin Microbiol Infect Dis (2014) 0.93
Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol (1998) 0.92
Local recurrence after breast cancer affects specific survival differently according to patient age. Oncology (2011) 0.91
Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix. Calcif Tissue Int (2003) 0.90
IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. Int Immunopharmacol (2011) 0.90
Focal lesion of African histoplasmosis presenting as a malignant gastric ulcer. Hepatogastroenterology (1997) 0.90
Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. J Pathol (1997) 0.90
Improved four-color flow cytometry method using fluo-3 and triple immunofluorescence for analysis of intracellular calcium ion ([Ca2+]i) fluxes among mouse lymph node B- and T-lymphocyte subsets. Cytometry (1996) 0.89
Genetic imbalances in preleukemic thymuses. Biochem Biophys Res Commun (2001) 0.89
[Clinical case of the month. Intrapulmonary lung sequestration diagnosed in an adult]. Rev Med Liege (2011) 0.89
Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses. Neuropathol Appl Neurobiol (2015) 0.89
Effect of interferon-gamma and tumor necrosis factor-alpha on lymphoepithelial interactions within thymic nurse cells. Eur J Immunol (1990) 0.88
The thymus as a neuroendocrine organ. Synthesis of vasopressin and oxytocin in human thymic epithelium. Ann N Y Acad Sci (1987) 0.88
Viral glycoproteins in herpesviridae granulomas. Am J Dermatopathol (1994) 0.88
Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium. Vaccine (2012) 0.88
The neurohormonal thymic microenvironment: immunocytochemical evidence that thymic nurse cells are neuroendocrine cells. Neuroendocrinology (1988) 0.87
Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha. Am J Pathol (1995) 0.87
Improving emergency obstetric care in Mozambique: the story of Sofala. Int J Gynaecol Obstet (2006) 0.87
Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol (1996) 0.87
Clastogenic factors as biomarkers of oxidative stress in chronic hepatitis C. Digestion (2000) 0.87
Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue. Clin Exp Allergy (2013) 0.86
Marrow-thymus interactions during radiation leukemogenesis in C57BL/Ka mice. Cancer Res (1981) 0.86
Correlation of histology and detection of human papillomavirus DNA in vulvar cancers. Gynecol Oncol (1991) 0.86
Herpes simplex virus reactivation and dental procedures. Clin Oral Investig (2013) 0.86
CD28-B7 costimulatory blockade by CTLA4Ig delays the development of retrovirus-induced murine AIDS. J Virol (1998) 0.85
Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development. Immunology (1999) 0.85
Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of two cases. Acta Gastroenterol Belg (2001) 0.85
Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol (2004) 0.85
Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch (2000) 0.85
Analysis by in situ hybridization of cells expressing mRNA for tumor-necrosis factor in the developing thymus of mice. Dev Immunol (1992) 0.84
[Cause of death determined at autopsy in the University Hospital of Liège. Developments from 1878 to 1986]. Rev Med Liege (1992) 0.84
Congenital mesoblastic nephroma and trisomy 11. Cancer Genet Cytogenet (1998) 0.84
Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol (1999) 0.84
Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis. Hepatogastroenterology (2001) 0.84
DNA sequences 3' of the Ig H chain cluster rearrange in mouse B cell lines. J Immunol (1991) 0.83
Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch (1995) 0.83
Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations. Histopathology (1993) 0.83
Tamoxifen-associated steatohepatitis--report of three cases. J Hepatol (1995) 0.83